Top compounds associated with response to SRI


Feature Type Standardized
Nominal ANOVA
mRNA GDC-0941 GDSC1000 pan-cancer AAC -0.038 0.3
mRNA KIN001-260 GDSC1000 pan-cancer AAC -0.036 0.3
mRNA cimetidine CTRPv2 pan-cancer AAC 0.079 0.3
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.038 0.3
mRNA AP-24534 GDSC1000 pan-cancer AAC -0.038 0.3
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.044 0.3
mRNA AZD6482 CTRPv2 pan-cancer AAC 0.042 0.3
mRNA lomeguatrib CTRPv2 pan-cancer AAC -0.042 0.3
mRNA PLX4720 CCLE pan-cancer AAC -0.05 0.3
mRNA BRD-K90370028 CTRPv2 pan-cancer AAC -0.062 0.3
Download CSV